Magnesium measurement in routine clinical practice
Magnesium is the fourth most abundant cation in the body and is quantitatively the most important intracellular divalent cation. I In health, plasma magnesium concentration varies between 0·65 and 1·05 mmol/L, About 20--30% of this is cornplexed to proteins and 30% to various other ligands, while 50--60% exists as free ionized magnesiurn.i-' Plasma magnesium comprises about I % of the total body magnesium content.
Magnesium functions in biology as a counterion for important intracellular anionic ligands, notably adenosine triphosphate (ATP), and acts as a physiological calcium competitor for binding sites on proteins and membranes." Many enzymes require magnesium, including those controlling important metabolic pathways and signalling systems. A number of reviews of the role of magnesium in biochemistry are available.' 7 As the central role of magnesium in biochemistry becomes clearer, and with the advent of suitable methods for routine clinical application, calls for the inclusion of magnesium in routine biochemical profiles become more acceptable.V' A general consensus has been reached on the indications for measurement of serum magnesium; these are presented in Table I . Hospitalized patients with conditions or treatments which predispose to magnesium depletion require serum magnesium analysis at least weekly. As a general rule, patients regarded as at risk of potassium depletion should also be regarded as at risk of magnesium depletion.l' 7.9 as up to 40% of hypokalaernic patients are also hypomagnesaernic.?
The desirable assay characteristics in terms of bias and precision have been discussed in great This article was prepared under the auspices of the Analytical Investigations Standing Committee of the Association of Clinical Biochemists. detail by a number of experts. 1 {}- 12 The current European consensus view appears to be that quality specifications are best based on biological parameters. There are many data on the biological variation; the median within-subject variation (CV 1 ) is 3,2%, and the median between-subject variation (CV G ) is 5·9%. For analytical random variation (CVA) not to affect the true test result variability by more than about 10%, CVA should be less than 0·5 CV 1 for diagnosis and monitoring purposes. to Thus, for magnesium analysis, the desirable analytical imprecision is 1·6% or less.
In order to allow the use of common reference intervals between laboratories, systematic variation (bias) should be less than 0·25 (CV[2+CV G 2)1/2.1O For magnesium, the desirable bias therefore should be less than 1·7%. For quality assessment schemes that use single sample analysis, it is desirable that the acceptability criteria (total error) should also be based on biology, and calculated from the desirable imprecision and bias as 1·65 (0'5 CV 1 )+0·25 ([cv l+cVd)I/2.1O,12 For magnesium at P<0·05, this is 4·3%.
Unfortunately, the state of the art of magnesium assays fall, in general laboratory practice, well short of the desirable performance based on biological variability considerations. Approximate current performance standards (modified from UK NEQAS, reproduced with permission) for magnesium analysis as of January 1996 are presented in Table 2 . Our laboratory has an analytical imprecision of 3·1% for magnesium, so a result change of 12·5% (approximately 0·1 mrnol/L) must occur before one can be confident at P < 0·05 that a real change has occurred in the patient's sample. In 1993, the intra-laboratory imprecision of the best 20% of laboratories for magnesium analysis was 2·68% (ACB NewsSheet 1993; 365: 15). Clearly, there is considerable room for improvement in current methodology for magnesium measurement.
METHODS OF MEASUREMENT
Historical: gravimetric, titrimetric and flame emission Phosphate precipitation methods and compleximetric titration methods have been abandoned in clinical practice because of poor accuracy and other considerations. Flame emission has also been used in the past, but performance compares poorly with modern methods as magnesium emits poorly at low temperatures, and significant interference occurs as a result of sodium, potassium and phosphate emissions.P Flame emission photometry was initially used for magnesium analysis, because magnesium has a flame spectrum and a band emission with peaks at 370 and 383 nm and an arc line at 285·2 nm. The most significant interference in measurement at 370 and 383 nm in clinical practice is sodium, because of its greater emission intensity and higher concentration in serum. At these wavelengths, increased sensitivity can be achieved using a nitric acid/perchloric acid digest followed by evaporation to dryness, but this is not appropriate for general clinical applications. Considering these limitations and the widespread availability of better methods, flame emission has no role In current clinical laboratory practice.
Atomic absorption spectrophotometry
The potential use of atomic absorption spectroscopy (AAS) for analytical purposes was first proposed in 1955, and a method for the determination of magnesium using this approach was described in 1958. 14 The basis of the method is the measurement of the light absorbed at the wavelength of the resonance line (285'2 nm for magnesium) by the unexcited atoms of the element. The reduced spectral interference, increased specificity, good detection limits and relative simplicity, as compared with flame emission techniques, soon enabled AAS to supersede flame emission as the flame technique of choice for the analysis of many metals, including magnesium.
The temperature of the acetylene-oxygen flame can be lower than in emission studies, because the magnesium atoms are required to be in the ground state to absorb the appropriate radiation. Also, the monochromator slit width is not as critical because the magnesium hollow cathode lamp does not emit any other radiation bands near 285·2 nm to generate interference. The hollow cathode lamp has been the most popular light source used in atomic absorption spectroscopy; it is suitable for the analysis of most metals, including magnesium. Where calcium and magnesium are frequently analysed on the same instrument, combined calcium and magnesium hollow cathode lamps are available.
AAS has been established as a de facto reference method for magnesium analysis in clinical practice because of its specificity and accuracy." 18 AAS produces results with good precision and accuracy but, for routine clinical measurement purposes, is impractical for most laboratories. The equipment required is specialized and expensive to procure and maintain. The methodology is potentially hazardous as it involves a naked flame and the use of inflammable, explosive gases. The technique has a relatively narrow analytical range, is technically demanding and is difficult to automate. AAS requires frequent calibration and maintenance, and is expensive and slow compared to more recently introduced methods such as colorimetry. In research applications, both within-and between-batch CVs of less than I % can be achieved. In routine clinical practice, however, betweenbatch CVs of < 3% are more usual.
Since it is often necessary to measure calcium and magnesium simultaneously in clinical situations, it is more efficient to have a single predilution procedure for both elements as well as using a combined calcium and magnesium hollow cathode lamp. Within biological fluids, calcium and magnesium are partially complexed with phosphate and are unavailable for reduction to the ground state. Therefore, specimens are prediluted with solutions of lanthanum or stronti urn salts, which bind preferentially to phosphate and release the divalent cation. Dilution with lanthanum solution is typically I in 50 for serum specimens, but is much more variable for urine because of the wider concentration range of magnesium. For faecal or tissue samples, a wide variety of sample preparation techniques, based mainly on evaporation to dryness followed by acid or trypsin digestion, have been described. The majority of protocols for magnesium measurement by AAS are modifications of the method for calcium measurement developed by Bowers and Pybus," with variations to the concentrations of the release agent and the pH of the diluent solution.
Good general reviews of the utility of AAS are available.15.19.2o Several variants of AAS have been developed which overcome some of the drawbacks, but the methods are largely confined to specialized laboratories."
Photometric assays Photometric methods are currently the most commonly used methods in routine clinical chemistry laboratories for the measurement of magnesium. They rely on a range of metallochromic indicators, which change colour on selective binding of magnesium. Some of the indicators, such as eriochrome black T, fast blue BG, 8-hydroxyquinolone or titan yellow, are now of historical interest only. Several articles and reviews on early methods are available. 22 24 The titan yellow method is a good manual procedure for the estimation of magnesium,24.26 producing within-run CVs of below 3% throughout the physiological range of serum magnesium concentrations. However, the method requires I mL of serum, which renders it unsuitable for use with paediatric samples or with modern analysers.
Methylthymol blue is a popular colorimetric indicator and is used in the 'Du Pont ACA' method. Methylthymol blue methods are particularly subject to interference from bilirubin, but between-run CVs of 2·7% or less may be achieved." A serum with a total bilirubin concentration of 340 Ilmol/L gave a magnesium concentration of 0·37 rnmol/L, while the result by AAS was found to be 0·74 mmol/L (50% suppression). With serum bilirubin concentrations of 42·4--425 Ilmol/L, a nearly linear relationship can be demonstrated between the degree of negative interference in the assay and the serum bilirubin concentration. Other drawbacks include instability of the methylthymol blue-magnesium complex, resulting in some fading of the colour formed with magnesium over several hours. Once the reagents are mixed with serum, analysis must be carried out without delay. This method is linear up to 1·8 mrnol/L, which limits its clinical utility for undiluted serum.
Magon or xylidyl blue (I-azo-2-hydroxy-3-[2,4-dimethylcarboxanilido-]-naphthalene-I'-[2-hydroxybenzeneJ) forms a red complex with magnesium in alkaline solution. Magnesium can be quantified through either an increase in absorption of chelate at 520 nm or a decrease in absorption of xylidyl blue at 600 nrn, or both. 28.29 A within-run CV of 3·6% and a between-run CV of 5-6% can be achieved in routine practice. In the xylidyl blue method, calcium in serum or urine is generally chelated selectively by GEDTA or EGTA (included in the reagent mix) prior to analysis of magnesium in the sample. The xylidyl blue method is not affected by oxalate or fluoride in the sample, and there is no interference from bilirubin up to about 500 Ilmol/L. The method is linear to about 4 mmol/Lr'" The method has also been successfully applied to magnesium analysis in urine." Although Babinski and Marie found no interference by citrate in their initial evaluation of the magon method.i? other investigators disagree. 3o.32 Attempts to minimize interference from other cations, heavy metals, lipids and proteins include the addition of 'calciumspecific' chelating agents, such as EGTA, which is claimed to eliminate calcium interference up to a serum calcium concentration of approximately 4 mmol/L, The success of such 'elimination' procedures remains controversial. Individual laboratories would be well advised to include interference studies in kit evaluation protocols prior to choosing a colorimetric method for magnesium analysis.
Calmagite (3-hydroxy-4-[2-hydroxy-5-methylphenylazo]-l-naphthalenesulphonic acid) was originally proposed by Lindstrom and Diehl in 1960 as an indicator for magnesiurn.P and has become one of the most popular colorimetric methods in use today. Calmagite has a blank absorbance peak at 610 nm and a magnesiumcomplex absorbance peak at 520 nm, leading to some overlap. The use of a detergent (Empigen BB, 300 g/L; Albright and Wilson Ltd, Whitehaven, UK) shifts the blank absorbance peak to 655 nm, significantly decreasing the blank absorbance component of the final solution." 36 and minimizes matrix effects." The change in colour may be read as a monochromatic change in absorbance, or as a bichromatic method with readings taken simultaneously at 500 and 600 nrn." Although individual commercial kits vary, the 'calmagite' method is generally free from interference by bilirubin and hyperlipidaemia, and by haemolysis up to 150 mg/dl haemoglobin and phosphate up to 16 rnmol/L, Magnesium, of course, should not be measured in haemolyzed samples because of its high intracellular concentrations.
The 'calmagite' method is linear up to magnesium concentrations of about 3 mmol/L, rendering it suitable for most clinical purposes.
Calcium in concentrations greater than 10 mrnol/L saturates the EGTA and produces a coloured complex with 'calrnagite'. Although not a problem in serum analysis, analysis of urine or other fluids may become problematic. Gross elevations of magnesium (> 6 mmol/L) cause a 'qualitative' change in the colour formed with 'calmagite' from violet to dark purple, and can lead to serious errors in quantification of magnesium if samples or fluids with high magnesium concentrations are not diluted appropriately. This is a particular problem with urine samples, which may have magnesium concentrations above 10 mmol/L. Within-batch CVs of 2·3-2'6% and between-batch CVs of 2·3-4·8% are quoted as being achievable in practice, depending on the manufacturer and instrumentation. The method achieves a high correlation with AAS for plasma and urine samples with no significant bias." The 'calrnagite' method has been adapted for automation,36.3K.w and is currently the second most popular method, after xylidyl blue, for routine magnesium analysis in clinical chemistry laboratories in the UK.
Enzymatic assays
Enzymatic assays are based on the specific requirements for magnesium of a number of enzymes, particularly those involved in glycolysis and carbohydrate metabolism. Typical coupled reaction sequences are shown in Table 3 .
Hexokinase utilizes the magnesium-ATp2complex to phosphorylate glucose at the '6' position, The glucose-6-phosphate (G-6-P) is dehydrogenated by G-6-P dehydrogenase using nicotinamide adenine dinucleotide phosphate (NADP+), thereby producing NADPH. The amount of NADPH produced in 15 min is measured after stopping the reaction with ethylenediaminetetraacetate (EDTA) and measuring absorbance at 340 nm. The final absorbance is proportional to the amount of magnesium-ATP complex forrned.t" The method, as originally described, is time consuming and unsuitable for routine use in a clinical laboratory, but has been automated for use on a centrifugal analyser."! The hexokinase method is free from significant interference by calcium up to 5 mrnolrl, and by phosphate up to 10 mmol/ L; however, as would be expected when measuring at 340 nm, it is prone to interference by lipaemia. Analytical performance is comparable with colorimetric methods with within-and between-batch CVs of below 3% being obtained throughout the physiological range of serum magnesium. The method correlates well with AAS (r = 0'99). 40.41 A faster method based on the glycerol kinase reaction was published by Wimmer et alY This uses a peroxidase-catalyzed reaction to form an intense red product proportional to the magnesium content in serum and measured at 510 nm. This method couples glycerol kinase, glycerophosphate oxidase and peroxidase using 4aminoantipyrine/2-hydroxy-3,5-dichlorobenzcne sulphonate (HDCBS, Research Organics Inc., Cleveland, Ohio, USA) as the chromogen, which is read at 510 nm. This is a kinetic method and more easily automated than that of Tabata et al. 40 The method is linear up to 2 rnrnol/L and free from interference by calcium (up to 5 rnmol/ L). Bilirubin interference is common in peroxidase-linked systems, but this method is apparently free from such interference up to a bilirubin concentration of approximately 350 J.lmol/LY However, bilirubin concentrations in excess of this are often seen in clinical practice. The reported within-run CV (2'6%) and between-run CV (3'6%) compare well with colorimetric methods.f A glucokinase-based method was developed by Fossati et al. 43 This enzyme has an absolute and specific requirement for activation by the magnesium-A'Tl'": complex. The enzyme is stable over a wide range of temperature and pH, and is available in pure forrn.r' The reaction is coupled to reduction of NADP and the change in absorbance is measured at 340 nm. The
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increase in absorbance is proportional to the amount of activated glucokinase, which, in turn, is directly proportional to the concentration of magnesium in the sample. This method is linear up to 2·06 mrnol/L in serum and correlates closely with atomic absorption spectrophotometry (r = 0'99) and the xylidyl blue colorimetric method (r = 0'99) over the working range.P
The glucokinase method is suitable for automation and has very good precision of less than 3·5% (MAGNESIUM; enzymic UV method, publication number SM4-,2211L95, Bayer Corporation, Tarrytown, NY, USA). The glucokinase method is free from interference by a wide range of cations which may be present in biological samples (Na", K+, Ca ':" , Cu"", Fe"", Mn"", Zn"") as well as phosphate, carbonate and sulphate. The method is not influenced by bilirubin up to 342 J.lmol/L or by haemoglobin; however, haemolyzed samples should be avoided because of the high magnesium content. The method is affected by EDTA for obvious reasons.
A method based on 'modified' isocitrate dehydrogenase has recently been developed by Fujita et al., 45 and is available commercially (Genzyme Diagnostics, Kent, UK). Data provided by the distributors suggest that the method correlates well with AAS and xylidyl blue methods up to 5·0 mmol/L, Within-run and between-run precision is good with no interference from bilirubin up to 500 J.lmol/L or calcium up to 10 rnmol/L." Other enzymic methods have been developed which relate magnesium-A'TP formation to the rate of reaction of a magnesium-dependent coupled process with NADH as the end point. Examples include procedures based on pyruvate kinase and lactate dehydrogenase," but to date these have not been made commercially available.
It is interesting that enzymatic methods correlate so well with measures of total magnesium rather than with ionized magnesium, since ionized magnesium is believed to represent the biologically active fraction in a manner analogous to calcium. Tabata et al. 40 speculated that enzymatic methods for magnesium analysis may strip magnesium from protein binding sites in favour of magnesium-ATP complex formation, possibly because of a higher affinity of magnesium for the ATP ligand. This question was addressed by Wimmer et al.,42who obtained results supporting the concept of dissociation of the protein-magnesium complex in these reagent systems.
Enzymatic methods combine the simplicity of photometric techniques with the specificity of atomic absorption, without the requirement for sophisticated equipment. They offer satisfactory throughput rates for most laboratories and good performance characteristics, and are readily automated. Enzymatic systems overcome, to a greater or lesser degree, the interference by other cations, heavy metals, proteins and lipaemia, which can be problematic for chemically-based colorimetric systems. Enzymatic methods have not yet gained widespread acceptance in routine laboratory practice, possibly because of a combination of the relative lack of readily available commercial kits and the high level of clinical satisfaction with colorimetric assays.
Dry chemistry systems
A method for magnesium determination using a dry chemistry system is available. This method uses a formazan dye (I-5-bis[3,5-dichloro-2hydroxyphenyl]-3-formazan carbonitrile), which forms a coloured complex. The multilayer film has a scavenger layer which entraps calcium using a specific chelator N ,N'-(I ,2-ethanediylbis[ oxy-2, I-phenylene])bis(N-carboxymethyl)glycine (BAPTA). Magnesium ions enter the lower layers and react with the formazan dye at pH 9·5. The resulting coloured complex is measured by reflectance photometry at 630 nm. The method is linear to about 4 mrnol/L, and results compare well with AAS, being approximately 5% lower at 4 mmol/L." Between-batch CVs of2·4-3·3% are achieved across the normal range of serum magnesium.
Thin-film methods are less subject to interference by bilirubin than are automated colorimetric methods." Calcium has a small but complex effect on magnesium measurement in dry chemistry systems. For each I mrnol/L of calcium above 2 mmol/L, measured magnesium increases by only 0·03 mmol/L. As discussed above, this falloff in performance at higher serum calcium concentrations may reflect 'stripping' of magnesium from proteins trapped in the upper layers of the film.
Ion-selective electrodes
The complex relationship between serum magnesium, serum proteins and other ligands has led to a drive for measurement of serum ionized magnesium in a manner analogous to calcium. Approximately 20-30% of total serum magnesium is protein-bound, possibly at the same site as calcium. 48-5o While simple algorithms exist for Ann Clin Biochem 1998: 3S 'correction' of total calcium for albumin concentration." no such algorithms exist for magnesium.V Direct measurements of ionized magnesium, rather than calculated estimations, are recommended by experts in the field. 50.52
Ionized magnesium measurements are usually made with simultaneous measurement of ionized sodium, potassium, calcium and pH, which are used by on-board software to 'correct' ionized magnesium prior to display of the result using a variety of algorithms. The software algorithms are experimentally derived using aqueous solutions and reflect the multiplicity of factors influencing the ionized fraction of total magnesium. The operating principle is based on the selectivity of magnesium-binding ligands such as ETH 7025. 53 Thus, while ionized calcium measurement is a stable and mature technology with well-defined clinical applications, 51 the clinical status of ionized magnesium measurement remains uncertain. 52.53
However, despite current limitations, the development of ionized magnesium electrodes and the search for definitive clinical applications continues.P 56 Results using magnesiumselective electrodes correlate well with atomic absorption for aqueous samples. A wide variety of anions may be present in patients' samples (e.g. lactate, bicarbonate, phosphate, heparin) which can lower ionized magnesium in a concentration-related manner to a variable degree. In addition, the complexing of ionized magnesium to anions is pH-dependent and may be affected by the change from in vivo to in vitro conditions during sampling, introducing additional complexity. Reference values for serum ionized magnesium obtained by these methods are 0'554 ± 0·057 mmol/L for men and 0·553 ± 0·053 rnrnol/L for women (mean±SD).55 This represents a percentage of total serum magnesium of 60% for men and 62% for women. The reference range for ionized magnesium in healthy ambulant subjects is O'53-{)·67 mmol/L, 56 Magnesium-selective electrode methods are generally linear up to about 4·5 mmol/L54.55 These methods achieve within-run CVs of approximately 3·5% and between-run CVs of about 12% across the physiological range of ionized magnesium concentrations. Consensus information on biological variation, and analytical and desirable performance criteria applicable to routine clinical practice, is not currently available. The 'manufacturer effect', whereby ionized magnesium electrodes are provided as part of the electrode block, has offered the potential for a direct comparison of the usefulness of ionized versus total serum magnesium concentration in a wide variety of patients. No such study has been reported in a routine clinical setting, and the clinical utility of ionized magnesium measurement remains contentious. Most hospitals do not seem to use ionized magnesium data in routine clinical management even where they are available.
Intracellular methods
Intracellular free magnesium (ionized magnesium) is a necessary cofactor for hundreds of enzymes. Intracellular free magnesium is generally believed to reach a concentration of about I mrnol/L. 3.6.57 This is near the K m of numerous enzymes, and minor changes in intracellular free magnesium may exert large influences on intracellular metabolism." The methodology of measurement of intracellular free magnesium has been reviewed by Alvarez-Leefmans et al., and interested readers are referred to their review.V A wide variety of fluorescent probes which are sensitive to chelation state are suitable for the measurement of free magnesium inside living cells in both the stimulated and unstimulated state, but none has been used in clinical applications to date." 60, 62, 63 Because of its propensity to form ATP complexes, magnesium measurement has proved a suitable application of 31p magnetic resonance spectroscopy, which has the additional potential benefit of being capable of measuring equilibrium state information i/1 vivD. 6I. 63 Red cell magnesium The magnesium content of red blood cells has been shown to be a poor predictor of magnesium status in muscle cells, where most of the body's intracellular magnesium resides." The entire magnesium content of both plasma and erythrocytes represents about I% of total body magnesium. Erythrocytes contain about \·7-2·7 mrnol/L magnesium.t" No consistent relationship has been found between red cell magnesium content and the magnesium content of other tissues. Mononuclear blood cells are generally considered to be superior to erythrocytes for serial evaluation of magnesium status in human subjects. 65 -6 7 Many techniques for the preparation of mononuclear cells from peripheral human blood have been described. Technical problems still limit the application of
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intracellular magnesium measurement in routine clinical practice. Clinical interest in the use of red cell magnesium concentrations dates back to studies such as that of Cox et al. in 1991 . 6H Red cell magnesium concentration was proposed as an indicator of total body magnesium in chronic fatigue syndrome, generating much popular and professional interest. In this study, whole blood and plasma magnesium were measured by AAS, and red cell magnesium concentration was calculated using percentage packed cell volume. In a study of 32 patients with chronic fatigue syndrome, red cell magnesium calculated by this method was found to be low, and clinical improvement was demonstrated following intramuscular injections of magnesium sulphate. While the study generated considerable professional and public interest, the findings could not be substantiated by further studies.P-" In summary, the role of red cell magnesium measurement in clinical practice remains controversial.
SAMPLE REQUIREMENTS
Methods for the measurement of magnesium have been developed for a wide variety of biological fluids and tissues. In routine clinical practice, only serum, plasma and urine measurements are generally required. There are no significant differences between magnesium concentrations in serum or heparinized plasma in routine clinical practice, and reference ranges are interchangeable. Citrate, EDTA and oxalate anticoagulants cause falsely low results as a result of either chelation of magnesium in the sample or precipitation of magnesium as a salt. Icterus or lipaemia can interfere with magnesium measurement using colorimetric methods, and the use of a sample blank is required for obviously icteric or haemolyzed samples if another sample cannot be obtained. Haemolysis is a major problem for magnesium analysis, with a calculated error of 7·6% increase in measured magnesium per gram of haemoglobin."
Albumin and magnesium concentrations are linearly related at high and low albumin concentrations, but within the reference interval for albumin magnesium is independent of albumin concentration.50 Magnesium concentration in serum is increased with delay in separation from cells. With storage at 4°C, a delay in separation of 24 h causes an II % increase in measured magnesium concentration in serum." For clinical purposes, blood samples should be taken without a tourniquet and separated from cells without undue delay.
Trichloroacetic acid can falsely increase zinc and magnesium concentrations as measured by atomic absorption." Colorimetric and enzymatic methods for the measurement of magnesium in biological fluids are remarkably free from drug interference. Physiological effects of drugs on magnesium metabolism are, however, numerous," and the effects of magnesiumbased antacids on drug absorption must also be kept in mind. 76 Urine samples should be acidified to pH 1·0 at collection to prevent precipitation of magnesium complexes. Urinary magnesium concentrations are highly variable and may require serial dilution prior to analysis. The kidneys are the main organ of magnesium homeostasis and can reduce magnesium loss during periods of depletion, provided homeostatic mechanisms are not compromised by drugs such as nephrotoxic agents or diuretics. Urinary magnesium loss is approximately 3·00-5·00 mmol/24 h, but is highly variable and depends on a wide variety of factors, including degree of metabolic stress, drug therapy, nutritional status and metabolic rate. Relatively little research has been done on the best urinary sample for the evaluation of magnesium status. Complete 24-h collections are preferred. A comparative study with timed or spot urinary collections, or magnesium excretion in relation to creatinine, supported the use of 24h collections." Fractional excretion of magnesium is generally between 3 and 5% of filtered load, but is highly variable. The kidney has the ability to conserve magnesium in response to magnesium deficit, making interpretation of urinary magnesium excretion difficult unless serial data are available or the measurement is part of a magnesium-loading test protocoIM.7~.79
METHOD COMPARISON
Basic data comparing a variety of methods for the analysis of magnesium in routine clinical practice are presented in Table 4 . Figures will vary between instruments and laboratories, and some information allowing direct comparisons between imprecision and bias is unavailable. It is clear that, as stated above, current methodology falls short of desirable performance characteristics. Colorimetric methods based on either calmagite or xylidyl blue offer the best option for most laboratories in terms of performance, but quoted figures vary widely between suppliers. It is clearly in the best interests of laboratories to perform their own evaluations on their own instruments prior to choosing any particular method.
CONCLUSION AND RECOMMENDAnONS
An increasing number and range of methods are becoming available for the measurement of magnesium in biological fluids. With increasing clinical interest in the cation, the demand for simple, robust methodology has generated a wide variety of ready-to-use kits and a general drift away from AAS. Measurement of total magnesium is still considered to be sufficient for most clinical purposes, and routine measurement of serum ionized magnesium is generally not required. Further improvements in technology and greater clinical experience with ionized magnesium measurements are likely to improve our understanding of the clinical role of magnesium and the clinical applications of its measurement.
The relatively poor analytical performance of colorimetric and enzymatic kits, in relation to the biological variation in serum magnesium concentrations, renders serial monitoring particularly important in the evaluation of clinical status. Changes in serum magnesium of the order of 0·1 mrnol/L must occur before one can be confident of a genuine change in magnesium concentration in serum, but no studies to date have directly addressed the clinical implications of such poor analytical performance. It is possible that clinically significant information is masked by the 'noise' of the current assay procedures. Each laboratory should search for kits that optimize the performance of its instrument.
